United Therapeutics (UTHR) Ranks 1st in Renaissance Technologies 2026 List
Published on 5/30/2026
AI Summary
Summarized by AI from the source belowUnited Therapeutics Corporation (UTHR) is ranked 1st on Renaissance Technologies' list of top stocks for 2026. The fund disclosed its initial stake of 261,000 shares in UTHR in Q4 2010. As of Q1 2026, Renaissance owns nearly 1.8 million shares, a decrease of over 6% from Q4 2025. The company is preparing major NDA submissions to the FDA for Tyvaso, which aims to be the first inhaled anti-fibrotic treatment for Idiopathic Pulmonary Fibrosis, following positive data from its TETON studies.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News
Earnings
Goldman Sachs and JPMorgan Chase Post Strong Q2 Revenues Driven by AI
Jul 14
Earnings
3 Canadian ETFs for TFSA Investors to Consider Holding Long-Term
Jul 14
Earnings
IBM Workers Face $400 Million Loss on Company Stock Investment
Jul 14
Earnings
SK Hynix Options Debut with 150,000 Contracts Traded on Tuesday
Jul 14